116 related articles for article (PubMed ID: 12380880)
1. Immunity to tetanus in male adults in Dar es Salaam, Tanzania.
Aboud S; Lyamuya EF; Kristoffersen EK; Matre R
East Afr Med J; 2002 Feb; 79(2):73-6. PubMed ID: 12380880
[TBL] [Abstract][Full Text] [Related]
2. Levels and avidity of antibodies to tetanus toxoid in children aged 1-15 years in Dar es Salaam and Bagamoyo, Tanzania.
Aboud S; Matre R; Lyamuya EF; Kristoffersen EK
Ann Trop Paediatr; 2000 Dec; 20(4):313-22. PubMed ID: 11219170
[TBL] [Abstract][Full Text] [Related]
3. Tetanus immunity among pregnant women attending antenatal care in Dar es Salaam, Tanzania.
Aboud S; Lyamuya EF; Kristoffersen EK; Matre R
Afr J Reprod Health; 2002 Aug; 6(2):87-93. PubMed ID: 12476720
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to tetanus toxoid in women of childbearing age in Dar es Salaam and Bagamoyo, Tanzania.
Aboud S; Matre R; Lyamuya EF; Kristoffersen EK
Trop Med Int Health; 2001 Feb; 6(2):119-25. PubMed ID: 11251908
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
7. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
Nohynek H; Gustafsson L; Capeding MR; Käyhty H; Olander RM; Pascualk L; Ruutu P
Pediatr Infect Dis J; 1999 Jan; 18(1):25-30. PubMed ID: 9951976
[TBL] [Abstract][Full Text] [Related]
8. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
9. Immunity and immunization of children against tetanus in sweden.
Christenson B; Böttiger M
Scand J Infect Dis; 1991; 23(5):643-7. PubMed ID: 1767261
[TBL] [Abstract][Full Text] [Related]
10. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
Vandermeulen C; Theeten H; Rathi N; Kuriyakose S; Han HH; Sokal E; Hoppenbrouwers K; Van Damme P
Vaccine; 2015 Jun; 33(26):3026-34. PubMed ID: 25613716
[TBL] [Abstract][Full Text] [Related]
11. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
[TBL] [Abstract][Full Text] [Related]
12. [Antibody levels for diphtheria, tetanus and pertussis in young adult females immunized with whole cell pertussis-diphtheria-tetanus toxoid vaccine in infancy].
Meno Y; Okada K; Yamaguchi Y; Morokuma K; Okuma K; Ueda K
Kansenshogaku Zasshi; 2000 Feb; 74(2):150-4. PubMed ID: 10741006
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
14. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
Pasetti M; Eriksson P; Ferrero F; Manghi M
Infection; 1997; 25(6):339-45. PubMed ID: 9427051
[TBL] [Abstract][Full Text] [Related]
16. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
Plosker GL
BioDrugs; 2009; 23(4):253-67. PubMed ID: 19697967
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
[TBL] [Abstract][Full Text] [Related]
18. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
19. Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso.
Rümke HC; Schlumberger M; Floury B; Nagel J; van Steenis B
Vaccine; 1993; 11(11):1113-8. PubMed ID: 8249429
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
